High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis-Reference-Cited by-同舟云学术

High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis

Published:2015-02-10 Issue:7 Volume:172 Page:1769-1782
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Oxombre B¹²,Lee-Chang C¹²,Duhamel A¹³,Toussaint M¹⁴,Giroux M¹²⁵,Donnier-Maréchal M¹⁶,Carato P¹⁶,Lefranc D¹²,Zéphir H¹²⁵,Prin L¹²⁷,Melnyk P¹⁴⁶⁸,Vermersch P¹²⁵

Affiliation:

1. Université de Lille; Lille France

2. UDSL; EA2686-LIRIC; UFR Médecine; Lille France

3. UDSL; EA 2694; UFR Médecine; Lille France

4. CNRS UMR8161; Lille France

5. Centre Hospitalier Régional et Universitaire de Lille; Pôle de neurologie-Service de Neurologie D; Lille France

6. UDSL; EA 4481; UFR Pharmacie; Lille France

7. Centre Hospitalier Régional et Universitaire de Lille; Pôle d'immunologie-Centre de Biologie Pathologie et Génétique; Lille France

8. Inserm UMR-S1172; Jean-Pierre Aubert Research Center; Lille France

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13037/fullpdf

Reference65 articles.

1. The Concise Guide to PHARMACOLOGY 2013/14: Overview;Alexander;Br J Pharmacol,2013a

2. The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors;Alexander;Br J Pharmacol,2013b

3. The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors;Alexander;Br J Pharmacol,2013c

4. The Concise Guide to PHARMACOLOGY 2013/14: Ligand-Gated Ion Channels;Alexander;Br J Pharmacol,2013d

5. Immunocytochemical localization of the sigma-1 receptor in the adult rat central nervous system;Alonso;Neuroscience,2000

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders;CNS Drugs;2023-05

2. Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis;International Journal of Molecular Sciences;2022-10-06

3. SK2 channels set a signalling hub bolstering CAF-triggered tumourigenic processes in pancreatic cancer;Gut;2022-09-01

4. Using sigma-ligands as part of a multi-receptor approach to target diseases of the brain;Expert Opinion on Therapeutic Targets;2020-08-31

5. Sigma-1 receptor agonists as potential protective therapies in multiple sclerosis;Journal of Neuroimmunology;2020-05